Skip to content
Screener

Stryker SYK Orthopaedics — Selling, general and administrative expenses

Other segment segments

MedSurg and Neurotechnology:
$930M+8.3%

Similar metrics at other companies

Lear Corporation logo
LEASeating — Selling, general and administrative expenses
$97.9M+14.5%
Knife River logo
KNFCentral — Selling, general and administrative expenses
$23.27M+26.0%
Ameresco logo
AMRCU.S. Federal — Selling, general and administrative expenses
$4.77M+74.5%
Tejon Ranch logo
TRCMineral resources — Selling, general and administrative expenses
$96K-48.9%
Tapestry, Inc. logo
TPRCoach — Selling, general and administrative expenses
$743.8M+24.3%
Ameresco logo
AMRCEurope — Selling, general and administrative expenses
$6.33M+27.2%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$129.28B-9.8%
Enterprise value$140.08B-11.2%
P/E34.7×-14.5×
P/S-1.0×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Segment ResultsThree Months / 2026Three Months / 2025
Orthopaedics146158
Segment research, development and engineering expenses$377$366
MedSurg and Neurotechnology$930$859
Orthopaedics880925
Segment selling, general and administrative expenses$1,810$1,784
MedSurg and Neurotechnology$55$48
Orthopaedics119107
Segment depreciation and amortization$174$155

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's orthopaedics — selling, general and administrative expenses?
Stryker (SYK) reported orthopaedics — selling, general and administrative expenses of $880M in Q1 2026.
How has Stryker's orthopaedics — selling, general and administrative expenses changed year-over-year?
Stryker's orthopaedics — selling, general and administrative expenses decreased by 4.9% year-over-year, from $925M to $880M.
What is the long-term trend for Stryker's orthopaedics — selling, general and administrative expenses?
Over 3 years (2022 to 2025), Stryker's orthopaedics — selling, general and administrative expenses has grown at a 7.2% compound annual growth rate (CAGR), from $2.61B to $3.21B.
What does orthopaedics — selling, general and administrative expenses mean?
This captures the overhead costs associated with selling, marketing, and managing the Orthopaedics business segment. It includes sales force compensation, administrative salaries, and general corporate support allocated to the segment. Managing these expenses is essential for maintaining segment profitability while supporting the complex sales process required for orthopedic implants.

Ask your AI about Stryker's orthopaedics — selling, general and administrative expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude